← FDA DRUG APPROVALS

FDA ANDA · ANDA206224

ALBUTEROL SULFATE

Sponsor: LUOXIN AUROVITAS

APPLICATION
ANDA206224
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-17
LATEST ACTION
2017-10-17
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.083% BASE · SOLUTION · INHALATION

Approval history

2017-10-17UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →